Connection

Dariusz Pytel to Tumor Cells, Cultured

Back to Details
This is a "connection" page, showing publications Dariusz Pytel has written about Tumor Cells, Cultured.
Dariusz Pytel
Connection Strength
0.055
Tumor Cells, Cultured
  1. Use of Small-molecule Inhibitory Compound of PERK-dependent Signaling Pathway as a Promising Target-based Therapy for Colorectal Cancer. Curr Cancer Drug Targets. 2020; 20(3):223-238.
    View in: PubMed
    Score: 0.040
  2. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Mutat Res. 2006 Jan 31; 603(1):74-82.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.